I expected daratumumab to garner FDA approval sometime after ASH. So when I saw a news alert earlier today announcing that Darzalex had been approved, I didn’t pay any attention. But it didn’t take long for me to figure out that Darzalex is the new trade name for daratumumab. By any name, this is wonderful news.

Darzalex becomes the first immunotherapy approved for use against multiple myeloma.

I’ll pass along more details tomorrow.

We should all be celebrating! Darzalex may not work for all of us, but it should work for most–especially if used after one of the first relapses.

Feel good and keep smiling! Pat